Glenmede Trust CO Na Athersys, Inc Transaction History

Glenmede Trust CO Na

  • $19.6 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 16, 2020
BUY
$1.91 - $3.08 $7,640 - $12,320
4,000 Added 47.06%
12,500 $24,000
Q3 2019

Nov 14, 2019
SELL
$1.21 - $1.65 $6,050 - $8,250
-5,000 Reduced 37.04%
8,500 $11,000
Q4 2018

Feb 14, 2019
SELL
$1.41 - $2.16 $12,690 - $19,440
-9,000 Reduced 40.0%
13,500 $19,000
Q3 2017

Nov 14, 2017
BUY
$1.5 - $2.55 $33,750 - $57,374
22,500
22,500 $0

About ATHERSYS, INC

ATHX Quotes by TradingView
  • Ticker ATHX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 305,110,016
  • Market Cap $3.05M
  • Description
  • Athersys, Inc., a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused on treating neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary and other conditions. The company's lead platform product i...
More about ATHX
Track This Portfolio

Track Glenmede Trust CO Na Portfolio

Follow Glenmede Trust CO Na and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Glenmede Trust CO Na, based on Form 13F filings with the SEC.

News

Stay updated on Glenmede Trust CO Na with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email